Jubilant Pharmova Limited
NSE: JUBLPHARMA.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Priyavrat Bhartia
- Employees
- 5,399
- Headquarters
- Noida, India
- IPO year
- 2002
- Market cap
- ₹159.7B
- Website
- https://www.jubilantpharmova.com
Loading JUBLPHARMA…
Loading profile data…Frequently asked questions about JUBLPHARMA
What does Jubilant Pharmova Limited (JUBLPHARMA.NS) do?
Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile inject...
Where does JUBLPHARMA.NS trade?
Jubilant Pharmova Limited (JUBLPHARMA.NS) trades on the National Stock Exchange of India.
What sector is JUBLPHARMA.NS in?
Jubilant Pharmova Limited (JUBLPHARMA.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Jubilant Pharmova Limited?
Priyavrat Bhartia is the chief executive officer of Jubilant Pharmova Limited (JUBLPHARMA.NS).
Where is Jubilant Pharmova Limited headquartered?
Jubilant Pharmova Limited is headquartered in India.
Does JUBLPHARMA.NS pay a dividend?
Yes — Jubilant Pharmova Limited (JUBLPHARMA.NS) paid a trailing twelve-month dividend of INR 5.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did JUBLPHARMA.NS go public?
Jubilant Pharmova Limited (JUBLPHARMA.NS) completed its initial public offering in 2002.